Elevance Health Q2 2022 Earnings Report
Key Takeaways
Elevance Health's Q2 2022 results showcased strong financial performance with double-digit growth in revenue, operating earnings, and adjusted earnings per share. The company reported an increase in medical enrollment and has raised its outlook for 2022 earnings per share.
GAAP net income was $6.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $8.04 per share.
Operating revenue grew 15.6% over the prior year quarter to $38.5 billion.
Operating gain grew 13.7% over the prior year quarter to $2.4 billion.
Medical enrollment increased 2.7 million members year-over-year and 276 thousand members during the quarter to 47.1 million members.
Elevance Health
Elevance Health
Elevance Health Revenue by Segment
Forward Guidance
The Company now expects GAAP net income to be greater than $25.28 per share, including approximately $3.42 per share of net unfavorable items. The Company now expects full-year adjusted net income to be greater than $28.70 per share, based on stronger than expected results year-to-date.
Revenue & Expenses
Visualization of income flow from segment revenue to net income